HomeRGNT • NYSEAMERICAN
add
Regentis Biomaterials Ltd
Previous close
$7.07
Day range
$7.14 - $7.18
Year range
$7.00 - $7.63
Market cap
33.13M USD
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 219.50K | 123.44% |
Net income | -1.61M | -144.79% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 189.00K | 7.39% |
Total assets | 475.00K | 141.12% |
Total liabilities | 9.71M | 155.70% |
Total equity | -9.23M | — |
Shares outstanding | 3.93M | — |
Price to book | -0.03 | — |
Return on assets | -115.53% | — |
Return on capital | 51.29% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.61M | -144.79% |
Cash from operations | -170.00K | -5,766.67% |
Cash from investing | — | — |
Cash from financing | 150.00K | 271.43% |
Net change in cash | -20.00K | 76.33% |
Free cash flow | -137.19K | -123.44% |
About
Founded
2004
Website
Employees
6
